The global ”erectile dysfunction market” size is estimated to grow incrementally owing to the increasing prevalence of the condition on a global scale, states Fortune Business Insights™ in an upcoming report, titled, “Erectile Dysfunction Market Size, Share & Industry Analysis, By Treatment Type (Drugs [Sildenafil, Tadalafil, Vardenafil, Avanafil, Others] Penile Implants, Penis Pumps, Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Pharmacies, Others)and Regional Forecast, 2020-2027.” Common causes of erectile dysfunction could be health related conditions such as cardiovascular diseases, hypertension, diabetes, and others.
The COVID-19 pandemic is growing to be the biggest health emergency of all times. The unprecedented spread of the novel coronavirus has led countries to enforce nationwide, prolonged lockdowns, due to which businesses across the world have come to a standstill. At Fortune Business Insights™, we closely study the market from various perspectives in order to identify new growth opportunities. We offer better decision making capabilities and actionable insights through our comprehensive market reports based on our expertise and experience in the field of market research.
Request a Sample Copy of the Research Report:
Increasing Cases of Erectile Dysfunction in U.S. to Help North America Dominate
North America is anticipated to account for the largest share of the global dysfunction market owing to the increasing number of men suffering from erectile dysfunction in the region. For instance, according to a report by Current Opinion in Nephrology and Hypertension, about 35 million men have been affected by the condition in the U.S.
The Europe erectile dysfunction market is set to deliver an impressive growth in the projected timeline. Increasingelderly population, coupled with the development in the treatment options of the condition is expected to drive the growth in the region.
Drivers & Restraints-
Sedentary Lifestyle of Working Population Worldwide to Drive Growth
According to a research by the International Journal of Impotence, the number of men suffering from erectile dysfunction is estimated to reach 322 million by 2025. The steady growth in these numbers is expected to increase the treatment rate of the disease, giving a robust boost to the growth of the global erectile dysfunction market. In addition, the prevalence of smoking and alcoholism in the current lifestyle of the working population worldwide is expected to further enhance growth. However, expensive treatment and the lack of awareness regarding the same are expected to hinder growth.
Highlights of the Report:
While making the report we incorporated the market ranking of major players along with their new service/product launches, partnerships, business expansions, and acquisitions. The dynamics of the market were closely studied along with the growth opportunities in the years to come. Our next step included qualitative and quantitative analysis of the market based on segmentation, involving both economic as well as non-economic factors. In addition, we thoroughly observed the current, as well as future outlook of the industry with respect to the recent developments.
Offering Innovative Products to Help Key Players Gain High Share
The global market for erectile dysfunction comprises various multinational and local players that are consistently expanding the industry across regions. They are focusing on launching innovative products in order to successfully expand their shares. For instance, in July 2019, Boston Scientific Corporation launched a natural-feeling implant to treat erectile dysfunction.
Have Any Query? Ask Our Experts:
- In February 2019, Dr. Reddy’s Laboratory launched Tadalafil tablets in the U.S. market. These pills are made for the treatment of erectile dysfunction.
- In September 2019, Lupin launched Sildenafil tablets for the treatment of erectile dysfunction in the U.S. market.
A List of Key Manufacturers Operating In the Global Erectile Dysfunction Market Report:
- Pfizer Inc.
- Bayer AG
- Eli Lilly and Company
- Apricus Biosciences, Inc.
- Mylan N.V.
- GlaxoSmithKline plc
- Boston Scientific Corporation
- Reddy’s Laboratory
What are the key segments in the market?
By Treatment Type
- Penile Implants
- Penis Pumps
By End User
- Hospitals & Clinics
- Ambulatory Surgery Centers
- North America (USA, Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)
With tables and figures helping analyse worldwide Global erectile dysfunction Market Forecast provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245